(Q70266958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6346850%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Prostanoids in platelet-vascular interactions (English)

1 reference

Cardiology and cardiovascular medicine

10 October 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

4 October 2023

author name string

T. J. Martin

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6346850

1

1 reference

4 October 2023

I. L. Smith

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6346850

2

1 reference

4 October 2023

R. D. Nolan

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6346850

3

1 reference

4 October 2023

G. J. Dusting

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6346850

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6346850%20AND%20SRC:MED&resulttype=core&format=json

4 October 2023

language of work or name

English

0 references

publication date

1 July 1983

1 reference

10 October 2019

20 July 1983

1 reference

National Center for Biotechnology Information

PubMed ID

6346850

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6346850

full work available at URL

4 October 2023

https://api.elsevier.com/content/article/PII:000291498390173X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

https://api.elsevier.com/content/article/PII:000291498390173X?httpAccept=text/plain

4 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

American Journal of Cardiology

4 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6346850%20AND%20SRC:MED&resulttype=core&format=json

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6346850%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6346850%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

22A-27A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6346850%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

2

1 reference

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

10 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

4 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Humoral heartache -- do platelets have a role?

4 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

4 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

4 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis

4 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

4 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane A2

4 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets

4 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

4 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Mode of action of dipyridamole on human platelets

4 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium

4 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

4 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials

4 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Comparison of plasma concentrations of thromboxane B2in prinzmetal's variant angina and classical angina pectoris

4 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Stimulation of prostacyclin release from the epicardium of anaesthetized dogs

4 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits

4 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta

4 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation

4 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Production of 6-oxo-prostaglandin F1alpha by rat aorta: influence of diabetes, insulin treatment, and caloric deprivation

4 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Decreased vascular prostacyclin in experimental diabetes

4 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Vascular prostacyclin may be reduced in diabetes in man

4 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Human dermal microvascular endothelial cells in vitro: Effect of cyclic AMP on cellular morphology and proliferation rate

4 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Prostacyclin (PGI2) release accompanying angiotensin conversion in rat mesenteric vasculature

4 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Phospholipase inhibition and the mechanism of angiotensin-induced prostacyclin release from rat mesenteric vasculature

4 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Stimulation of Endothelial Cell Prostacyclin Production by Thrombin, Trypsin, and the Ionophore A 23187

4 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Histamine stimulate prostacyclin synthesis in cultured human umbilical vein endothelial cells

4 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor

4 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Generation of prostacyclin by lungs in vivo and its release into the arterial circulation

4 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Prostacyclin is a circulating hormone

4 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Measurement of circulating prostacyclin

4 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin

4 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Inactivation of vascular prostacyclin synthetase by platelet lipoxygenase products

4 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

4 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Prostacyclin therapy in peripheral arterial disease

4 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase

4 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity

4 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

Bovine endothelial cells in culture produce thromboxane as well as prostacyclin

4 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90173-X

4 October 2023

Identifiers